HEPARIN
Hypogonadotropic Hypogonadotropism
University of Colorado, DenvermixtureN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
5 Active assets in the Hypogonadotropic Hypogonadotropism cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
TESTOSTERONE UNDECYLATE Canisius-Wilhelmina Hospital | Phase 4 | A |
Metformin University Medical Centre Ljubljana | Phase 4 | BBB |
Arimidex Baylor College of Medicine | Phase 4 | BBB |
Liraglutide University Medical Centre Ljubljana | Phase 4 | BB |
Testim Odense University Hospital | Phase 4 | BB |
View all 24 →
Same molecule, other indications
HEPARIN is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →